Latest news
Dimensional Fund Advisors LP Has $12.87 Million Stock Position in Cullinan Therapeutics, Inc. $CGEM - MarketBeatMarketBeat · Sun, 09 Aug 2026 07:33:23 GMTCullinan Therapeutics (NASDAQ:CGEM) Issues Quarterly Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 03:25:30 GMTRenaissance Technologies LLC Sells 307,595 Shares of Cullinan Therapeutics, Inc. $CGEM - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:44:45 GMTCullinan Therapeutics (NASDAQ:CGEM) Lowered to Sell Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 01 Aug 2026 05:14:06 GMTCullinan Therapeutics (NASDAQ:CGEM) Shares Down 7.3% - Here's What Happened - MarketBeatMarketBeat · Fri, 31 Jul 2026 07:00:00 GMTCullinan Therapeutics (CGEM) Expected to Release Quarterly Earnings on Thursday - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTCullinan Therapeutics (NASDAQ:CGEM) Price Target Raised to $39.00 - MarketBeatMarketBeat · Wed, 29 Jul 2026 07:00:00 GMT